The popularity of Viagra initially fueled a surge for major pharmaceutical companies, but recent changes present a murky outlook for investors. Lower-cost competitors are eating into profits, and persistent litigation https://dawudzaej645377.tusblogos.com/41828298/the-blue-pill-and-big-pharma-a-precarious-play